Georg Aichinger

This paper develops a fermentation workflow to assess gut microbiome biotransformation capacity using chemical probes and metabolomics, showing that experimental conditions and donor variability influence transformation profiles.

The paper predicts human internal exposure to alternariol and AME using a PBK model, finding concentrations far below toxic thresholds.

This study investigates bidirectional interactions between fluorinated chemicals and gut microbiota using ex vivo, in vitro, and in silico methods, revealing microbial biotransformation and potential detoxification effects.

The paper predicts internal exposures of bisphenol analogs using physiologically based kinetic models with multimodal parameterization, showing variability in concentrations by age, sex, and organ.

This study shows that sulfoquinovose is not metabolized by mice or humans but is degraded by gut microbiota, with differences in degradation pathways between mice and humans.

The paper profiles chemical activities in rat gut microbiota to assess changes in biotransformation capacity after exposure to drugs and dietary compounds, finding significant alterations with certain antibiotics.

The paper develops a physiologically based kinetic model to predict in vivo concentrations of hop phytoestrogens in human blood and tissues under dietary exposure.